Catalytic topoisomerase II inhibitors suppress the androgen receptor signaling and prostate cancer progression

被引:1
|
作者
Li, Haolong [1 ]
Xie, Ning [1 ]
Gleave, Martin [1 ]
Dong, Xuesen [1 ]
机构
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
10.1158/1538-7445.AM2015-1846
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1846
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression
    Li, Haolong
    Xie, Ning
    Gleave, Martin E.
    Dong, Xuesen
    [J]. ONCOTARGET, 2015, 6 (24) : 20474 - 20484
  • [2] Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression
    Schaefer-Klein, J. L.
    Murphy, Stephen J.
    Johnson, Sarah H.
    Vasmatzis, George
    Kovtun, Irina V.
    [J]. PLOS ONE, 2015, 10 (11):
  • [3] Interaction of IGF signaling and the androgen receptor in prostate cancer progression
    Wu, Jennifer D.
    Haugk, Kathy
    Woodke, Libby
    Nelson, Peter
    Coleman, Ilsa
    Plymate, Stephen R.
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (02) : 392 - 401
  • [4] Catalytic topoisomerase II inhibitors in cancer therapy
    Larsen, AK
    Eseargueil, AE
    Skladanowski, A
    [J]. PHARMACOLOGY & THERAPEUTICS, 2003, 99 (02) : 167 - 181
  • [5] Androgen receptor signaling in prostate cancer
    Zoran Culig
    Frédéric R. Santer
    [J]. Cancer and Metastasis Reviews, 2014, 33 : 413 - 427
  • [6] Androgen receptor signaling in prostate cancer
    Culig, Zoran
    Santer, Frederic R.
    [J]. CANCER AND METASTASIS REVIEWS, 2014, 33 (2-3) : 413 - 427
  • [7] Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer
    Thomas, Jeffrey D.
    Longen, Charles G.
    Oyer, Halley M.
    Chen, Nan
    Maher, Christina M.
    Salvino, Joseph M.
    Kania, Blase
    Anderson, Kelsey N.
    Ostrander, William F.
    Knudsen, Karen E.
    Kim, Felix J.
    [J]. CANCER RESEARCH, 2017, 77 (09) : 2439 - 2452
  • [8] Androgen receptor involvement in the progression of prostate cancer
    Suzuki, H
    Ueda, T
    Ichikawa, T
    Ito, H
    [J]. ENDOCRINE-RELATED CANCER, 2003, 10 (02) : 209 - 216
  • [9] Regulation of androgen receptor signaling in prostate cancer
    Dehm, SM
    Tindall, DJ
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (01) : 63 - 74
  • [10] Androgen receptor signaling and mutations in prostate cancer
    Koochekpour, Shahriar
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2010, 12 (05) : 639 - 657